Practice-Changing Viral Hepatitis Data From AASLD 2022

In this episode, Nancy Reau, MD, shares her thoughts on the most practice-changing viral hepatitis data from AASLD 2022, including:

• Novel therapeutics for HBV
• HCV management strategies
• HDV screening and linkage to care
• Fatty liver disease in persons with viral hepatitis
• Use of statins to decrease morbidity and mortality in persons with liver disease

Presenter:

Nancy Reau, MD
Professor of Medicine
Chief, Section of Hepatology
Associate Director
Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
Chicago, Illinois

Link to full program: 
https://bit.ly/3Y1tD6f

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.